A Food and Drug Administration advisory panel met to discuss regulatory approval for the Alzheimer's drug, Leqembi.

Share:
More In Science
FDA Updates Ozempic Label
The Food and Drug Administration updated the labeling for Ozempic acknowledging reports of blocked intestines for those that use the medication.
Load More